Huang J, Ali T, Feldman D, Theise N
Diagnostics (Basel). 2024; 14(14).
PMID: 39061609
PMC: 11276095.
DOI: 10.3390/diagnostics14141473.
Choi S, Pan E, Elliott A, Beltran H, Panian J, Jamieson C
Mol Cancer Res. 2024; 22(10):920-931.
PMID: 38912907
PMC: 11850019.
DOI: 10.1158/1541-7786.MCR-24-0395.
Zhang X, Li H, Wang Y, Zhao H, Wang Z, Chan F
Cell Death Dis. 2024; 15(3):234.
PMID: 38531859
PMC: 10965960.
DOI: 10.1038/s41419-024-06621-w.
Kalyanaraman H, Casteel D, Pal China S, Zhuang S, Boss G, Pilz R
Sci Signal. 2024; 17(821):eadi7861.
PMID: 38289986
PMC: 10916501.
DOI: 10.1126/scisignal.adi7861.
Horton C, Liu Y, Wang J, Green J, Tsyporin J, Chen B
Stem Cell Reports. 2023; 18(6):1355-1370.
PMID: 37172587
PMC: 10277819.
DOI: 10.1016/j.stemcr.2023.04.003.
Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance.
Martinez S, Elix C, Ochoa P, Sanchez-Hernandez E, Alkashgari H, Ortiz-Hernandez G
Int J Mol Sci. 2023; 24(8).
PMID: 37108293
PMC: 10139020.
DOI: 10.3390/ijms24087130.
Anoikis in phenotypic reprogramming of the prostate tumor microenvironment.
Nepali P, Kyprianou N
Front Endocrinol (Lausanne). 2023; 14:1160267.
PMID: 37091854
PMC: 10113530.
DOI: 10.3389/fendo.2023.1160267.
Aberrant androgen action in prostatic progenitor cells induces oncogenesis and tumor development through IGF1 and Wnt axes.
Kim W, Olson A, Mi J, Wang J, Lee D, Le V
Nat Commun. 2022; 13(1):4364.
PMID: 35902588
PMC: 9334353.
DOI: 10.1038/s41467-022-32119-0.
Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer.
Miller K, Asim M
Cells. 2022; 11(6).
PMID: 35326402
PMC: 8946764.
DOI: 10.3390/cells11060952.
Endocrine Disruptors and Prostate Cancer.
Corti M, Lorenzetti S, Ubaldi A, Zilli R, Marcoccia D
Int J Mol Sci. 2022; 23(3).
PMID: 35163140
PMC: 8835300.
DOI: 10.3390/ijms23031216.
TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer.
Wen Y, Liu Y, Yeh H, Chen W, Jiang K, Lin S
Oncogenesis. 2021; 10(11):81.
PMID: 34799554
PMC: 8604986.
DOI: 10.1038/s41389-021-00371-6.
Clinical and genomic features of SPOP-mutant prostate cancer.
Nakazawa M, Fang M, Marshall C, Lotan T, Velho P, Antonarakis E
Prostate. 2021; 82(2):260-268.
PMID: 34783071
PMC: 8688331.
DOI: 10.1002/pros.24269.
Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells.
Zhang Y, Liu Q, Wei W, Zhang G, Yan S, Dai R
BMC Cancer. 2021; 21(1):1101.
PMID: 34645397
PMC: 8515742.
DOI: 10.1186/s12885-021-08841-1.
Regulation of Wnt Signaling by FOX Transcription Factors in Cancer.
Koch S
Cancers (Basel). 2021; 13(14).
PMID: 34298659
PMC: 8307807.
DOI: 10.3390/cancers13143446.
Integrated Therapeutic Targeting of the Prostate Tumor Microenvironment.
Livas L, Hasani S, Kyprianou N
Adv Exp Med Biol. 2021; 1296:183-198.
PMID: 34185293
DOI: 10.1007/978-3-030-59038-3_11.
Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment.
Makino T, Izumi K, Mizokami A
Biomedicines. 2021; 9(4).
PMID: 33921329
PMC: 8069212.
DOI: 10.3390/biomedicines9040414.
Direct interaction of β-catenin with nuclear ESM1 supports stemness of metastatic prostate cancer.
Pan K, Lee W, Chou C, Yang Y, Chang Y, Chien M
EMBO J. 2020; 40(4):e105450.
PMID: 33347625
PMC: 7883293.
DOI: 10.15252/embj.2020105450.
High-Load Resistance Exercise Augments Androgen Receptor-DNA Binding and Wnt/β-Catenin Signaling without Increases in Serum/Muscle Androgens or Androgen Receptor Content.
Cardaci T, Machek S, Wilburn D, Heileson J, Willoughby D
Nutrients. 2020; 12(12).
PMID: 33333818
PMC: 7765240.
DOI: 10.3390/nu12123829.
Multifunctional Roles of the Actin-Binding Protein Flightless I in Inflammation, Cancer and Wound Healing.
Strudwick X, Cowin A
Front Cell Dev Biol. 2020; 8:603508.
PMID: 33330501
PMC: 7732498.
DOI: 10.3389/fcell.2020.603508.
Wnt and Vitamin D at the Crossroads in Solid Cancer.
Gonzalez-Sancho J, Larriba M, Munoz A
Cancers (Basel). 2020; 12(11).
PMID: 33227961
PMC: 7699248.
DOI: 10.3390/cancers12113434.